Home > PS Ratio > GUFIC BIOSCIENCES

GUFIC BIOSCIENCES
PS (Price/Sales) Ratio

The Current P/S Ratio of GUFIC BIOSCIENCES is 5.03.

Share Price ₹403.2Nov 22,2024
Market Cap ₹4,043.6 Cr
Sales-TTM₹803.8 CrTTM-Standalone Results
Price/Sales5.03xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for GUFIC BIOSCIENCES
Please provide your vote to see the results
GUFIC BIOSCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals

Definition & Calculation of PS (Price/Sales) ratio of GUFIC BIOSCIENCES

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of GUFIC BIOSCIENCES is calculated as :

Current Market Cap [ ₹4,043.6 Cr] as on Nov 22,2024

(/) Sales [ ₹803.8 Cr] based on TTM-Standalone Results

(=) P/S Ratio [ 5.03x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for GUFIC BIOSCIENCES , the investors are currently willing to pay '5.03 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of GUFIC BIOSCIENCES !

The chart below summarizes the trend in P/S Ratio of GUFIC BIOSCIENCES over the last five years.

Historical PS (Price/Sales) ratio chart of GUFIC BIOSCIENCES


PS Ratio Performance Analysis for GUFIC BIOSCIENCES

- GUFIC BIOSCIENCES 's latest p/e ratio is 5.03x.

- GUFIC BIOSCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.54x.

- GUFIC BIOSCIENCES 's operated at median p/e ratio of 2.62x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GUFIC BIOSCIENCES 's p/e ratio peaked in Mar2024 at 3.52x.

- GUFIC BIOSCIENCES 's p/e ratio hit its five-year low in Mar2020 of 1.21x.


How does GUFIC BIOSCIENCES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
GUFIC BIOSCIENCES 803.85.034,043.6
SUN PHARMACEUTICAL INDUSTRIES LTD50,307.78.57431,352.0
CIPLA LTD26,512.04.53120,035.0
DR REDDYS LABORATORIES LTD30,084.93.37101,286.0
ZYDUS LIFESCIENCES LTD21,483.54.4495,461.4
DIVIS LABORATORIES LTD8,614.018.49159,265.0
MANKIND PHARMA LTD11,018.09.28102,231.0
TORRENT PHARMACEUTICALS LTD11,225.09.56107,306.0
LUPIN LTD21,431.34.4194,430.6
AUROBINDO PHARMA LTD30,295.02.3571,069.8
ABBOTT INDIA LTD6,066.19.7058,859.9

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs GUFIC BIOSCIENCES 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.35x
Max industry PS 18.49x
Median industry PS 5.03x
Average industry PS 7.25x



You may also like the below Video Courses